Table 1.
Baseline characteristics of participants.
| Characteristics | All patients (n = 1,383) |
|---|---|
| Mean age ± SD (years) | 69.8 ± 14.4 |
| Men, n (%) | 738 (53.5) |
| NIHSS score, median (IQR)* | 16 (11–20) |
| Mean systolic blood pressure ± SD (mm Hg) | 150 ± 25 |
| MEDICAL HISTORY, N (%) | |
| Atrial fibrillation | 411 (30.7) |
| Hypertension | 697 (51.1) |
| Diabetes mellitus | 235 (17.1) |
| Myocardial infarction | 216 (15.9) |
| Peripheral artery disease | 127 (9.4) |
| Ischaemic stroke | 227 (16.5) |
| Hypercholesterolemia | 411 (29.7) |
| Pre-stroke mRS > 2, n (%) | 158 (11.6) |
| Smoking, n (%) | 314 (22.9) |
| MEDICATION USE, N (%) | |
| DOAC** | 35 (2.6) |
| Coumarine | 179 (13.0) |
| Antiplatelet | 461 (33.7) |
| Heparin | 52 (3.8) |
| Blood pressure medication | 707 (52.1) |
| Statin | 490 (36.2) |
| Intravenous alteplase treatment, n (%) | 1,054 (76.2) |
| ASPECTS, median (IQR) | 9 (7–10) |
| Time from stroke onset to groin in minutes, median (IQR) | 210 (160–270) |
| Collateral score ≥ 2 | 764 (55) |
*
National Institutes of Health Stroke Scale score.
**
Direct oral anticoagulant drugs.